188 related articles for article (PubMed ID: 21604976)
1. Emerging vector-borne flavivirus diseases: are vaccines the solution?
Gubler DJ
Expert Rev Vaccines; 2011 May; 10(5):563-5. PubMed ID: 21604976
[No Abstract] [Full Text] [Related]
2. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
[TBL] [Abstract][Full Text] [Related]
3. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.
Ishikawa T; Yamanaka A; Konishi E
Vaccine; 2014 Mar; 32(12):1326-37. PubMed ID: 24486372
[TBL] [Abstract][Full Text] [Related]
4. Flaviviruses and flavivirus vaccines.
Heinz FX; Stiasny K
Vaccine; 2012 Jun; 30(29):4301-6. PubMed ID: 22682286
[TBL] [Abstract][Full Text] [Related]
5. Vaccination for tropical mosquito borne encephalitis.
Wiwanitkit V
Acta Neurol Taiwan; 2009 Mar; 18(1):60-3. PubMed ID: 19537577
[TBL] [Abstract][Full Text] [Related]
6. New developments in flavivirus vaccines with special attention to yellow fever.
Pugachev KV; Guirakhoo F; Monath TP
Curr Opin Infect Dis; 2005 Oct; 18(5):387-94. PubMed ID: 16148524
[TBL] [Abstract][Full Text] [Related]
7. Dengue and other emerging flaviviruses.
Solomon T; Mallewa M
J Infect; 2001 Feb; 42(2):104-15. PubMed ID: 11531316
[TBL] [Abstract][Full Text] [Related]
8. The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus.
Yamshchikov G; Borisevich V; Kwok CW; Nistler R; Kohlmeier J; Seregin A; Chaporgina E; Benedict S; Yamshchikov V
Vaccine; 2005 Sep; 23(39):4785-92. PubMed ID: 15939510
[TBL] [Abstract][Full Text] [Related]
9. Emerging arboviral diseases.
Daniels PW
Aust Vet J; 2002 Apr; 80(4):216. PubMed ID: 12054284
[No Abstract] [Full Text] [Related]
10. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
11. Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination.
Kaaijk P; Luytjes W
Hum Vaccin Immunother; 2018 Feb; 14(2):337-344. PubMed ID: 29053401
[TBL] [Abstract][Full Text] [Related]
12. Advances in flavivirus vaccine development.
Coller BA; Clements DE; Martyak T; Yelmene M; Thorne M; Parks DE
IDrugs; 2010 Dec; 13(12):880-4. PubMed ID: 21154147
[TBL] [Abstract][Full Text] [Related]
13. Neuroinvasive flavivirus infections.
Sips GJ; Wilschut J; Smit JM
Rev Med Virol; 2012 Mar; 22(2):69-87. PubMed ID: 22086854
[TBL] [Abstract][Full Text] [Related]
14. Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections.
Monath TP; McCarthy K; Bedford P; Johnson CT; Nichols R; Yoksan S; Marchesani R; Knauber M; Wells KH; Arroyo J; Guirakhoo F
Vaccine; 2002 Jan; 20(7-8):1004-18. PubMed ID: 11803060
[TBL] [Abstract][Full Text] [Related]
15. American Society of Tropical Medicine and Hygiene--55th Annual Meeting. Vaccine development against flaviviruses. 12-16 November 2006, Atlanta, GA, USA.
Klade C
IDrugs; 2007 Feb; 10(2):96-8. PubMed ID: 17285458
[No Abstract] [Full Text] [Related]
16. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines.
Brandler S; Tangy F
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338
[TBL] [Abstract][Full Text] [Related]
17. Flavivirus DNA vaccines--good science, uncertain future.
Petersen LR; Roehrig JT
J Infect Dis; 2007 Dec; 196(12):1721-3. PubMed ID: 18190248
[No Abstract] [Full Text] [Related]
18. Recent advancement in flavivirus vaccine development.
Chang GJ; Kuno G; Purdy DE; Davis BS
Expert Rev Vaccines; 2004 Apr; 3(2):199-220. PubMed ID: 15056045
[TBL] [Abstract][Full Text] [Related]
19. Live flavivirus vaccines: reasons for caution.
Seligman SJ; Gould EA
Lancet; 2004 Jun; 363(9426):2073-5. PubMed ID: 15207960
[TBL] [Abstract][Full Text] [Related]
20. Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses.
Widman DG; Frolov I; Mason PW
Adv Virus Res; 2008; 72():77-126. PubMed ID: 19081489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
